Sarmal, Inc. logo — A genomics company developing next generation innovations in...

Sarmal, Inc.

A genomics company developing next generation innovations in sequencing and advanced target sequence detection

Founded 2019 Istanbul 5 employees Digital Health, Health Care +3

General Information

Company Name Sarmal, Inc.
Founded Year 2019
Location Istanbul
Employees 5
Industries Digital Health, Health Care, Health and Wellness +2
Social

Get notified when Sarmal, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sarmal, Inc.

Sarmal, Inc. is a genomics company focused on developing next generation innovations in sequencing and advanced target sequence detection. The company's FLASH Sequencing technology, a single molecule DNA sequencing approach, is a game changer in the genomics field, enabling whole genome sequencing at a cost of under $100 per genome using low-cost devices and boasting low error rates. Additionally, Sarmal, Inc. offers the DeTaiL Platform, a portable and field deployable nucleic acid-based diagnostic platform capable of achieving gold-standard specificity and sensitivity in just five minutes, making large population screening a reality. Founded in 2019, Sarmal, Inc. operates in the industries of Digital Health, Health Care, Health and Wellness, Healthtech, and Life Sciences. Despite the absence of disclosed details on their headquarters and last investment, Sarmal, Inc. presents a promising opportunity in the genomics and healthcare sectors for potential investors.

Taxonomy: Genomics, DNA sequencing, Target sequence detection, Sequencing technology, Nucleic acid-based diagnostics, Portable diagnostic platform, Field deployable technology, Single molecule sequencing, Next generation sequencing, Advanced sequencing technology, Diagnostic devices, Error rate reduction, Population screening, Cost-effective genomics

Services & Products

Development of next-generation innovations in sequencing and advanced target sequence detection

Target Customers

Research institutions biotechnology companies healthcare organizations

No funding data available for Sarmal, Inc. yet.

Get notified when Sarmal, Inc. raises funding

Sarmal, Inc. Alternatives & Competitors

Sarmal, Inc. vs
Phase Genomics
Phase Genomics United States

Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Epigenomics

Unknown
13 employees
Biotechnology, Clean Energy
Sarmal, Inc. vs
Cypher Genomics
Cypher Genomics United States

Unlocking the potential of human genome data through automated interpretation for clinical labs and...

Non Equity Assistance
2 employees
Analytics, Biotechnology
Sarmal, Inc. vs
SciGenom Labs
SciGenom Labs United States

Leveraging science of the genome.

18 employees
Biotechnology, Health Care
Also compare with: Sarmal, Inc. vs Complete Genomics Complete Genomics

FAQ About Sarmal, Inc.

A genomics company developing next generation innovations in sequencing and advanced target sequence detection
Sarmal, Inc. was founded in 2019.
Sarmal, Inc. is headquartered in Istanbul.
Sarmal, Inc. operates in the following industries: Digital Health, Health Care, Health and Wellness, Healthtech, Life Sciences.
Sarmal, Inc. has approximately 5 employees.
Sarmal, Inc. offers: Development of next-generation innovations in sequencing and advanced target sequence detection.
Top alternatives and competitors to Sarmal, Inc. include Phase Genomics, Cypher Genomics, SciGenom Labs, Genome Surveillance, Wobble Genomics Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sarmal, Inc. and Phase Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sarmal, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes